51. Novel treatment approaches and pediatric research networks in status epilepticus.
- Author
-
Bialer M, Cross H, Hedrich UBS, Lagae L, Lerche H, and Loddenkemper T
- Subjects
- Animals, Child, Humans, Sodium Channels genetics, Sodium Channels metabolism, Status Epilepticus drug therapy, Status Epilepticus genetics, Anticonvulsants therapeutic use, Pediatrics methods, Research, Status Epilepticus therapy
- Abstract
This paper contains five contributions which were presented as part of the novel therapies section of the 7th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures. These illustrate recent advances being made in the management and therapy of status epilepticus. The five contributions concern: genetic variations in Na + channel genes and their importance in status epilepticus; the European Reference Network for rare and complex epilepsies EpiCARE; the North American Pediatric Status Epilepticus Research Group (pSERG); Fenfluramine as a potential therapy for status epilepticus' and the valproate derivatives, valnoctamide and sec-butylpropylacetamide (SPD), as potential therapies for status epilepticus. This article is part of the Special Issue "Proceedings of the 7th London-Innsbruck Colloquium on Status Epilepticus and Acute Seizures"., (Copyright © 2019 Elsevier Inc. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF